Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) - Global Forecast to 2025

ヘルスケア分析試験サービスの世界市場予測:種類別(方法開発・検証、細胞ベースアッセイ、安定性試験、重金属試験、画像分析、ウイルス試験)、エンドユーザー別(医薬品、医療機器)

◆タイトル:Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) - Global Forecast to 2025
◆商品コード:AST 4341
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年4月30日
◆ページ数:328
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:産業機械
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はヘルスケア分析試験サービスの世界市場が、2020年49億ドルから2025年84億ドルまで、年平均11.4%成長すると予測しています。本調査レポートでは、ヘルスケア分析試験サービスの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、産業インサイト、種類別(方法開発・検証、細胞ベースアッセイ、安定性試験、重金属試験、画像分析、ウイルス試験)分析、エンドユーザー別(製薬会社・生物医薬品会社、医療機器会社、契約研究組織)分析、地域別分析、競争状況、企業概要などを含め、今後の方向性を提示しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・産業インサイト
・ヘルスケア分析試験サービスの世界市場:種類別(方法開発・検証、細胞ベースアッセイ、安定性試験、重金属試験、画像分析、ウイルス試験)
・ヘルスケア分析試験サービスの世界市場:エンドユーザー別(製薬会社・生物医薬品会社、医療機器会社、契約研究組織)
・ヘルスケア分析試験サービスの世界市場:地域別
・競争状況
・企業概要

“The healthcare analytical testing services market is projected to grow at a CAGR of 11.4%.”
The global healthcare analytical testing services market size is projected to reach USD 8.4 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 11.4% during the forecast period. Market growth is attributed to the shift of focus towards the analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and the adoption of FTE contracts in R&D outsourcing.

“By type, within the bioanalytical testing services segment, cell-based assay services hold the largest share in the forecast period.”
Based on type, the healthcare analytical testing services market has been segmented into bioanalytical testing services, physical characterization services, method development & validation services, raw material testing services, and batch-release testing services, among others. Bioanalytical testing services accounted for the largest share of the market in 2019. Within this segment, the cell-based assay services segment is expected to grow at the highest CAGR. This is due to their ability to provide relevant in vivo biological information in comparison to biochemical assays.

“By end user, the medical device companies segment is expected to grow at the fastest rate during the forecast period (2020-2025)”
Based on End User, the healthcare analytical testing services market has been segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and CROs. The medical device companies segment is expected to grow at the highest CAGR due to increasing demand by OEMs for more services and expertise, an evolving regulatory scenario, technological advancements in medical devices, and the adoption of POC testing.

“North America to hold the largest share.”
North America is expected to account for the largest share of the global healthcare analytical testing services market in 2019. The large share of this region can primarily be attributed to the presence of a well-established base of pharmaceutical and biopharmaceutical companies, high investments in the biosimilars and biologics segment, and increasing R&D expenditure. On the other hand, the APAC is expected to witness the highest CAGR during the forecast period due to the large number of qualified researchers, low cost of operations in APAC countries, presence of a large treatment-naïve population, retention of participants in clinical trials, and continuously improving regulatory procedures.

The breakdown of primary participants is mentioned below:
• By Company Type: Tier 1–30%, Tier 2–45%, and Tier 3–25%
• By Designation: C-level–35%, Director Level–25%, and Others–40%
• By Region: North America–35%, Europe–30%, the Asia Pacific–15%, Latin America–10%, Middle East & Africa – 10%

Research Coverage:
The report analyzes the various healthcare analytical testing services products and their adoption patterns in different industries such as pharmaceutical and biopharmaceutical companies, medical device companies, and CROs. It aims at estimating the market size and future growth potential of the global healthcare analytical testing services market for different segments such as by type, end user, and regions. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the service portfolios offered by the top players in the global healthcare analytical testing services market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global healthcare analytical testing services market
• Market Development: Comprehensive information on lucrative emerging regions, by type and end user.
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global healthcare analytical testing services market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and services offered by leading players in the global healthcare analytical testing services market

【レポートの目次】



★調査レポート[ヘルスケア分析試験サービスの世界市場予測:種類別(方法開発・検証、細胞ベースアッセイ、安定性試験、重金属試験、画像分析、ウイルス試験)、エンドユーザー別(医薬品、医療機器)] ( Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) - Global Forecast to 2025 / AST 4341) 販売に関する免責事項
[ヘルスケア分析試験サービスの世界市場予測:種類別(方法開発・検証、細胞ベースアッセイ、安定性試験、重金属試験、画像分析、ウイルス試験)、エンドユーザー別(医薬品、医療機器)] ( Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) - Global Forecast to 2025 / AST 4341) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆